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Abstract
Background: Skin toxicity is a common side effect of radiotherapy for solid tumors. Its
management can cause treatment gaps and thus can impair cancer treatment. At present, in many
countries no standard recommendation for treatment of skin during radiotherapy exists. In this
study, we explored the effect of topically-applied tea extracts on the duration of radiation-induced
skin toxicity. We investigated the underlying molecular mechanisms and compared effects of tea
extracts with the effects of epigallocatechin-gallate, the proposed most-active moiety of green tea.
Methods: Data from 60 patients with cancer of the head and neck or pelvic region topically
treated with green or black tea extracts were analyzed retrospectively. Tea extracts were
compared for their ability to modulate IL-1β, IL-6, IL-8, TNFα and PGE2 release from human
monocytes. Effects of tea extracts on 26S proteasome function were assessed. NF-κB activity was
monitored by EMSAs. Viability and radiation response of macrophages after exposure to tea
extracts was measured by MTT assays.
Results: Tea extracts supported the restitution of skin integrity. Tea extracts inhibited
proteasome function and suppressed cytokine release. NF-κB activity was altered by tea extracts
in a complex, caspase-dependent manner, which differed from the effects of epigallocatechin-
gallate. Additionally, both tea extracts, as well as epigallocatechin-gallate, slightly protected
macrophages from ionizing radiation
Conclusion: Tea extracts are an efficient, broadly available treatment option for patients suffering
from acute radiation-induced skin toxicity. The molecular mechanisms underlying the beneficial
effects are complex, and most likely not exclusively dependent on effects of tea polyphenols such
as epigallocatechin-gallate.
Background
Skin toxicity is a common side effect of external beam
radiotherapy in patients suffering from solid cancers.
Radiation technique has improved dramatically with the
introduction of linear accelerators, thereby reducing skin
toxicity. However, current treatment concepts often
include radiation dose escalation to improve tumor con-
trol, thereby surpassing normal tissue tolerance doses.
This often leads to the occurrence of moist skin desqua-
mation (RTOG grade ≥ 2 skin toxicity) [1], which causes
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ing and immediately after treatment. Moreover, clinical
management of radiation-induced skin toxicity often
requires radiotherapy treatment gaps, thereby reducing
the probability of loco-regional tumor control [2]. In the
past, many clinical efforts have been made to attenuate
skin toxicity in radiation therapy or to delay its onset, but
in many countries there is no "gold standard" in skin care
during and after radiation treatment. Instead, numerous
treatment recommendations exist, which have been estab-
lished empirically, but many compounds frequently used
in these protocols have failed to prove their efficacy in
clinical trials [3,4]. To date, the majority of previous stud-
ies have aimed to prevent or attenuate skin reactions but
did not focus on the duration of radiation-induced skin
toxicity, if present.
Patients with grade 2+ skin toxicity mostly suffer from
skin disintegrity and symptoms caused by inflammation
in the irradiated areas. Radiation-induced inflammation
is mainly caused by activation of NF-κB, a preformed
dimeric transcription factor sequestered in the cytosol by
its inhibitor molecules of the IκB-family. Following ioniz-
ing irradiation, IκB-kinases become activated and phos-
phorylate IκB at specific serine sites. This tags IκB for poly-
ubiquitination and subsequent degradation through the
26S proteasome [5], a multi-catalytic, ATP-dependent
protease complex, responsible for posttranslational con-
trol of all short-lived and many long-lived proteins.
Degradation of IκB frees NF-κB for translocation into the
nucleus, where it binds to specific consensus sequences in
promoter regions of NF-κB-dependent genes to initiate
transcription of pro-inflammatory cytokines [6].
Tea extracts are known to terminate inflammatory condi-
tions, and its usage has been reported to prevent skin
damage caused by UV irradiation [7]. There are three types
of tea: black, Oolong, and green tea. Green tea is widely
consumed in Japan, China, and other Asian nations and is
becoming more popular in Western nations. The differ-
ence between green tea and the others is that green tea is
not fermented, thus preventing antioxidants from being
lost during that process. Therefore, and in contrast to
black tea, green tea contains high concentrations of
polyphenols such as epigallocatechin-gallate (EGCG). Tea
polyphenols have been shown to inhibit proteasome
function, thereby terminating inflammation [8].
Although tea polyphenols have been claimed to be the
most potent constituents of tea, there is increasing evi-
dence that these compounds are not the only constituents
responsible for the beneficial effects on heath from tea [9].
In the present study, we analyzed the efficacy of our stand-
ard skin care program containing topically-applied black
or green tea extracts on the duration of grade 2+ skin tox-
icity during radiation therapy. We found green tea extracts
to be superior to black tea extracts in the treatment of radi-
ation-induced skin toxicity. Investigating the underlying
molecular mechanisms to understand how tea extracts
help to restore skin integrity, we observed that whole tea
extracts altered DNA-binding of the transcription factor
NF-κB in a complex manner, different from that seen after
EGCG treatment.
Methods
Patients
Data from 60 inpatients experiencing skin toxicity RTOG
score grade 2 and higher (grade 2+) during radiotherapy
at the Department of Radiation Oncology, University
Hospital Freiburg, Germany, were assessed retrospec-
tively. All patients received our standard skin care pro-
gram, which consisted of once-daily treatment of
irradiated skin areas with a moisturizing crème (Eucerin
Lotion 3% Urea, Beiersdorf AG, Hamburg, Germany)
starting at day one of radiation treatment (linear accelera-
tor Clinac, Varian, 6MeV photons; daily fractions of 1.8–
2.0 Gy). Frequency of application was increased to twice
or three times daily if a radiation-induced erythema
occurred, and stopped with the occurrence of moist desq-
uamation. Irradiated skin areas with grade 2+ lesions were
treated three times daily with either green or black tea
preparations for 10 minutes from the first day moist desq-
uamation was observed. Skin toxicity was scored by
nurses on a daily basis before every application of tea
extracts. Treatment with tea extracts was discontinued
immediately after the disappearance of moist desquama-
tion. Nine patients (four with head and neck cancer, four
with cancer in the pelvic region and one patient with
gliosarcoma) were released from the hospital with persist-
ing grade 2+ skin toxicity. These patients were censored
and the dataset was analyzed for the duration of skin tox-
icity grade 2+ using the Kaplan-Meier-Method. A p-value
≤ 0.05 (log-rank test) was considered statistically signifi-
cant. The study was approved by the local ethics board of
the University Hospital Freiburg, Germany.
Cell culture
Cultures of RAW 264.7 murine macrophages (a generous
gift of Dr G. Hildebrandt, Department of Radiation
Oncology, University of Leipzig, Germany) and MCF-7
breast cancer cells (DMSZ, Braunschweig, Germany) were
grown in 75 cm2 flasks (Greiner) at 37°C in a humidified
atmosphere at 5% CO2 in DMEM medium (Cell Con-
cepts, Umkirch, Germany), supplemented with 10% heat-
inactivated FCS and 1% penicillin/streptomycin (Sigma).
Isolation of human peripheral monocytes
Monocytes from healthy human donors were prepared
following a standardised protocol (Ficoll gradient prepa-Page 2 of 12
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toxin-free cultivation [10,11]. Using 50 ml tubes, 25 ml
Ficoll were loaded with 25 ml blood of buffy coats from
healthy blood donors. The gradient was established by
centrifugation at 1,800 r.p.m., 20°C for 40 min by using
slow acceleration and brakes. Peripheral blood mononu-
clear cells in the interphase were carefully removed and re-
suspended in 50 ml pre-warmed phosphate buffered
saline (PBS, Invitrogen) followed by centrifugation for 10
min at 1,600 r.p.m. and 20°C. The supernatant was dis-
carded and the pellet washed in 50 ml PBS and centri-
fuged as described above. The pellet was then re-
suspended in 50 ml RPMI-1640 low endotoxin-medium
(from Invitrogen) supplemented with 10% human serum
(PAA). After counting the amount of cells in a particle
counter (Euro Diagnostics, Krefeld), cells were seeded in
24-well plates for ELISA or six-well plates for RNA analysis
(1–2 × 106 cells/well) and incubated at 37°C/5% CO2.
The medium and the non-adherent cells (lymphocytes)
were removed and fresh RPMI-1640 medium containing
1% human serum was added.
Preparation of tea extracts
Two tea bags (1.5 g each) tea were covered with 50 ml Mil-
lipore water (black tea: boiling water; green tea: water at
70°C) for five minutes. The resulting extracts were passed
through a 0.8 µM and a 0.22 µM filter to free the extracts
from insoluble material. Small aliquots were stored until
usage at -20°C in the dark. Given a estimated total cate-
chin content of 10–40 mg/g for green tea [12], tea prepa-
rations used in our study, were expected to have an
estimated total catechin concentration of 25–100 µg/ml.
Epigallocatechin-gallate (Sigma-Aldrich) was solubilized
in water and small aliquots of the stock solution were
stored until usage at -20°C in the dark.
Irradiation of cells
Exponentially-growing RAW 264.7 murine macrophages
were irradiated at room temperature using a 137Cs-labora-
tory irradiator (IBL 637, CIS bio international) at a dose
rate of 0.78 Gy/min. Control cells were sham-irradiated.
MTT assay
Approximately 10,000 RAW 264.7 murine macrophages
per well were plated into 96-well plates in 100 µl RPMI
medium per well. After 24 h, tea extracts were added to the
media. Three hours later, the cells were irradiated with 0,
2, 4, 6, and 8 Gy. After five days, 20 µl MTT (5 mg/ml) was
added to each well and cells were subsequently incubated
for four hours at 37°C. Fifty microliters of a 20% SDS
solution (0.02 N HCL) was added to each well and
absorbance at 560 nm was measured after overnight incu-
bation at 37°C (VersaMax, Molecular Devices).
Proteasome function assays
Proteasome function was measured as described previ-
ously [13] with some minor modifications. To obtain
crude cellular extracts, cells were washed with PBS, then
with buffer I (50 mM Tris, pH 7.4, 2 mM DTT, 5 mM
MgCl2, 2 mM ATP), and pelleted by centrifugation (1,000
× g, 5 min, 4°C). Glass beads and homogenization buffer
(50 mM Tris, pH 7.4, 1 mM DTT, 5 mM MgCl2, 2 mM
ATP, 250 mM sucrose) were added and cells were vortexed
for 1 min. Beads and cell debris were removed by centrif-
ugation at 1,000 × g for 5 min and 10,000 × g for 20 min
at 4°C. Protein concentration was determined by the
Micro BCA protocol (Pierce) with BSA (Sigma) as stand-
ard. To measure 26 S proteasome activity, 10 µg protein of
crude cellular extracts or 1 µg protein of partially purified
proteasomes of each sample was diluted with buffer I to a
final volume of 200 µl. The fluorogenic proteasome sub-
strate SucLLVY-MCA (chymotrypsin-like, Sigma) was dis-
solved in DMSO and added in a final concentration of 80
µM in 1% DMSO. Proteolytic activity was continuously
monitored by measuring the release of the fluorescent
group 7-amido-4-methylcoumarin (AMC) in a fluores-
cence plate reader (SpectraMax Gemini, Molecular
Devices, 37°C) at 380/460 nm.
Cell extracts and electrophoretic mobility shift assays
For preparation of total cytosolic extracts, cells were dis-
lodged mechanically, washed with ice-cold PBS and lysed
in TOTEX-buffer (20 mM HEPES, pH 7.9, 0.35 mM NaCl,
20% glycerol, 1% Nonidet P-40, 0.5 mM EDTA, 0.1 mM
EGTA, 0.5 mM DTT, PMSF and aprotinin) for 30 minutes
on ice. Lysate was centrifuged at 12,000 × g for 5 min at
4°C. Protein concentration was determined using the
BCA protocol (Pierce) and bovine serum albumin (BSA,
Sigma) as standard. Fifteen micrograms of protein from
the resulting supernatant was incubated for 25 minutes at
room temperature with 2 µl BSA (10 µg/µl), 2 µl dIdC (1
µg/µl), 4 µl Ficoll-buffer (20% Ficoll 400, 100 mM
HEPES, 300 mM KCl, 10 mM DTT, 0.1 mM PMSF), 2 µl
buffer D+ (20 mM HEPES, 20% glycerol, 100 mM KCl, 0.5
mM EDTA, 0.25% NP-40, 2 mM DTT, 0.1 mM PMSF) and
1 µl of the [γ32P]-ATP labeled oligonucleotide (Promega,
NF-κB: AGT-TGA GGG GAC TTT CCC AGG). For a nega-
tive control, unlabeled oligonucleotide was added in 50-
fold excess. Gel analysis was carried out in native 4% acr-
ylamide/0.5% TBE gels. Dried gels were placed on a phos-
phor screen for 24 hours and analyzed on a phosphor
imager (Typhoon 9410, Amersham).
Determination of inflammatory parameters
For the analysis of IL-6, TNF-α, IL-1-β, IL-8 and PGE2
release, cells were preincubated with the green and black
tea solutions in the indicated concentrations for 30 min
before stimulation with LPS (10 ng/ml) for additional 24
h. After culture supernatants were harvested and centri-Page 3 of 12
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PGE2 in the supernatant were measured by ELISA (IL-6, IL-
8, TNF-α: Pelikine, distributed by HISS, Freiburg, Ger-
many) or EIA (PGE2: AssayDesign, distributed by
Biotrend, Köln, Germany) according to the manufac-
turer's instructions. All experiments were carried out in
triplicates using two-sided student's t-test for statistical
analysis (a p-value ≤ 0.05 was considered statistically sig-
nificant).
Results
Green tea extracts as supportive care for acute radiation-
induced skin reactions
During curative-intended radiation treatment of solid
cancer, many patients experience grade 2+ skin toxicity,
which can cause treatment gaps and thus limit the curabil-
ity of the cancer. Tea extracts have been applied in our
department empirically to terminate acute skin reactions
during radiation therapy, but their use has not been inves-
tigated systematically to date. In the present study, 60
patients treated with radiation therapy received our stand-
ard skin care program. Demographics of all patients are
shown in Table 1. The standard skin care program at the
Department of Radiation Therapy, University Hospital
Freiburg, consisted of thrice-daily topical application of
green or black tea extracts to skin regions with grade 2+
toxicity and continued as long as grade 2+ toxicity per-
sisted. Applying these treatments, we found no difference
in duration of grade 2+ skin reactions in patients treated
for cancer of the head and neck region between green or
black tea (Figure 1A, mean duration for green tea 16.5 ±
1.7 days, for black tea 17 ± 1.8 days, p = 0.64; log-rank
test). Patients treated for cancer of the pelvic region had a
shorter duration of grade 2+ skin toxicity if treated with
green tea extracts (Figure 1B, mean duration for green tea
16.3 ± 1.6 days, for black tea 22.2 ± 2.1 days, p = 0.014;
log-rank test). The most obvious difference between
patients treated for head and neck cancer and patients
treated for tumors of the pelvic region was that most of the
latter received radiochemotherapy (23/25). Subgroup
analysis of patients with cancers of the head and neck
region showed no advantage for patients treated with
green tea extracts (8/15) during radiochemotherapy.
However, the numbers of patients in these subgroups was
small and thus the reliability of the statistical analysis was
limited.
Tea extracts inhibit secretion of pro-inflammatory 
cytokines from activated monocytes
Our clinical observations led us to investigate possible
underlying molecular mechanisms by which tea extracts
could support skin restitution during and after radiother-
apy. A hallmark of radiation-induced inflammation is the
release of pro-inflammatory cytokines by immune cells.
In order to test if clinically-used tea extracts exhibit anti-
inflammatory effects in human immune cells we used
human monocytes isolated from buffy coats. Both black
tea and green tea extracts caused a significant concentra-
tion-dependent decrease of LPS-induced IL-1β, IL-6, IL-8,
TNFα and PGE2 secretion in to the media. While both
extracts showed clear anti-inflammatory activity, this
inhibitory effect was more pronounced in green tea
extracts reflecting the higher efficiency of green tea in the
clinical study (Figure 2A–J).
Table 1: Patient characteristics
Green tea Black tea All patients
Patients (total) 31 29 60
Male:Female 17:14 18:11 35:25
Age (years) 61 ± 2 62 ± 2.1 61 (36–86)
Radiotherapy 11 11 22
Chemoradiotherapy 20 18 38
Total radiation dose (Gy) 57.6 ± 1.9 60.4 ± 2.1 58.9 ± 1 (45–70.4)
Start of tea treatment (Gy) 46.5 ± 1.5 44.4 ± 1.5 45.6 ± 0.8
ite of irradiation
Head & neck region 17 14 31
Pelvic region 13 12 25
Other 1 3 4
Staging
T1 5 3 8
T2 8 10 18
T3 10 9 19
T4 6 3 9
Tx 2 4 6
Leukocytes (Tsd/µl) 5.1 ± 0.2 6.4 ± 0.2 5.7 ± 0.1
Hb (g/dl) 11.3 ± 0.4 11.8 ± 0.4 11.6 ± 0.2
CRP (mg/dl) 3.4 ± 0.1 5.0 ± 0.2 4.2 ± 0.07
BMI (kg/m2) 24.5 ± 0.8 24.8 ± 0.9 24.7 ± 0.4Page 4 of 12
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Duration of radiation-induced grade ≤ 2 skin toxicity in irradiated skin areasFigure 1
Duration of radiation-induced grade ≤ 2 skin toxicity in irradiated skin areas. (A) Patients treated for cancer of the 
head and neck region. (B) Patients treated for cancer of the pelvic region. p-values: log-rank test (green tea vs. black tea treat-
ment).
p=0.014
p=0.64
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Release of PGE2 (A, F), IL-6 (B, G), IL-1β (C, H), TNFα (D, I), and IL-8 (E, J) from human monocytes after LPS treatment (10 ng/ml) and pre-incubation with green or black tea extractsFigur 2
Release of PGE2 (A, F), IL-6 (B, G), IL-1β (C, H), TNFα (D, I), and IL-8 (E, J) from human monocytes after LPS 
treatment (10 ng/ml) and pre-incubation with green or black tea extracts. All measurements are expressed relative 
to the corresponding LPS-treated control (mean ± standard deviation; * p ≤ 0.05, ** p ≤ 0.01, Student's t-test).
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effects on proteasome function
To further study the effects of tea extracts on signal trans-
duction in immune cells, we used RAW 264.7 murine
macrophages instead of buffy-coat-derived monocytes as
a model because it was necessary to scale up the cell
number to yield enough protein for proteasome function
assays.
Tea extracts contain polyphenols, which have been shown
to inhibit proteasome function. Therefore, we decided to
test if tea preparations used in skin care during radiation
therapy also have inhibitory effects on the proteasome.
Crude extracts of exponentially-growing RAW 264.7 mac-
rophages were incubated with serial dilutions of green
and black tea extracts. Chymotryptic, tryptic and pepdi-
dyl-glutamyl 26S proteasome activity were continuously
monitored using a fluorogenic peptide assay. Green tea
extracts caused a concentration-dependent inhibition of
the chymotryptic 26S proteasome activity (46% ± 5.3 at
0.5% (p ≤ 0.001; two-sided Student's t-test), 9.9% ± 1.3 at
1% (p ≤ 0.001; two-sided Student's t-test). Green tea
extracts at concentrations of 2% and higher completely
inhibited chymotryptic 26S proteasome activity.
Extracts from black tea were even more effective. Concen-
trations of 0.5 % strongly inhibited chymotryptic 26S pro-
teasome activity to 8% ± 1.1 (p ≤ 0.001; two-sided
Student's t-test) of untreated controls. No remaining activ-
ity was detected at 1% or 0.5%. Comparable results were
found for the peptidyl-glutamyl 26S proteasome activity
(Table 2), However, inhibition of the tryptic activity by
black tea extracts was not dose-dependent at the concen-
trations used, and was almost already complete at 0.5%
concentration.
Tea extracts cause NF-κB cleavage by a caspase-
dependent mechanism
Observing an inhibitory effect of proteasome function, we
next tested if – as a consequence – NF-κB DNA-binding
activity was affected by tea extracts. Surprisingly, for both
extracts we observed an increase in NF-κB activity, which
was accompanied by a size -shift of the specific bands at
4% and 0.4% concentrations in the gel-shift assays. Fur-
ther dilutions caused a decrease in NF-κB DNA-binding
activity in experiments using black tea extracts, while the
same dilutions of green tea extract had no effect (Figure 3,
4). Supershift assays using an anti-p50 or anti-p65 anti-
body confirmed specificity of the shifted bands (Figure 5).
The observed size shift could be completely reversed by
pre-incubation of the cells with the pan-caspase inhibitor
z-VAD-fmk (50 µM) indicating involvement of caspases
(Figure 6). Further exploring the underlying mechanism,
we repeated the gel-shift experiments using EGCG in con-
centrations comparable to concentrations expected in tea
extracts [12]. NF-κB DNA-binding was increased at very
high concentrations of EGCG (400 µM), but showed
almost no change at all other concentrations used. A size
shift of the DNA-bound complex could not be detected
(Figure 7).
The pan-caspase inhibitor z-VAD-fmk non-specifically
inhibits a broad panel of caspases. In order to further
explore the involvement of caspases we used MCF-7
breast cancer cells, which are known to be functionally
deleted in caspase-3 [15]. Gel-shift experiments using oli-
gonucleotides containing the consensus binding
sequences for NF-κB failed to show a size shift of the spe-
cific bands for NF-κB (Figure 8).
We next investigated if tea extracts also altered the viabil-
ity and radiation response of RAW 264.7 murine macro-
phages. Cells were pre-incubated with different
concentrations of green and black tea extracts for four
hours and irradiated with 0, 2, 4, 6 and 8 Gy. EGCG at 400
µM and tea extracts at 4% concentrations caused a signif-
icant decrease of viability, consistent with activation of
the cellular death program. EGCG at 40 µM or green tea
extracts (0.4%) did not have a significant cytotoxic effect
while black tea extracts (0.4%) significantly decreased via-
bility to 73.6% ± 8 (p ≤ 0.05; two-sided Student's t-test) of
untreated control cells. Concentrations of 0.04% of either
Table 2: 26S Proteasome activity
Chymotryptic Tryptic Pedidyl-glutamyl
Green tea
0.5% 46% ± 5.3** 62.7% ± 6.1** 62.7% ± 3.5*
1% 9.9% ± 1.3** 25.7% ± 3.9** 37.1% ± 17.1*
2% ND 1.8% ± 1.4** 12.6%+ ± 0.7**
Black tea
0.5% 8.0% ± 1.1** 3.1%+ ± 0.7** 50.7% ± 7.1**
1% ND 10.4% ± 5.7** 11.2% ± 9.3**
2% ND 6.5% ± 0.001** ND
*p < 0.05, **p < 0.001, ND: non-detectablePage 7 of 12
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EGCG (40 µM), green tea extracts (0.4%) and black tea
extracts (0.4%) caused a slight radioprotection (Figure 9).
Discussion
In this study, we showed that a skin care program contain-
ing topically-applied tea extracts for radiation-induced
grade 2+ skin lesions helped to restore skin integrity. Data
on the duration of grade 2+ skin toxicity is very rare in the
literature. However, green tea extracts in our study
appeared to be an efficient treatment as a previous study
reported duration of skin toxicity to be 22 days for anal
carcinomas and 26 days for head and neck cancers [16].
Using in-vitro models we demonstrated that tea extracts
attenuated the release of pro-inflammatory cytokines and
terminated pro-inflammatory signaling by caspase-
dependent and caspase-independent mechanisms.
In patients with cancer of the pelvic region, in the majority
treated with radiochemotherapy, green tea preparations
were significantly more effective than extracts from black
tea in decreasing the duration of grade 2+ skin toxicity. A
possible explanation for the superiority of green tea in
patients with cancer of the pelvic region might be the fact
that most of these patients suffered from anal carcinomas.
By the size, location, and shape of the radiation fields,
treatment of anal carcinoma often induces grade 2+ skin
toxicity in the inguinal regions and the rima ani, and these
lesions are prone to bacterial superinfections. Green tea is
known for its comparably higher content of polyphenols
[12], which exhibit considerable antibacterial activity,
especially against gram-positive bacteria such as S. aureus
[17], often found in superinfected skin lesions of hospital-
ized patients. The higher content of polyphenols may
therefore account for the shorter duration of grade 2+ tox-
icity in patients treated with green tea extracts. This indi-
cated that the underlying mechanisms of the benefical
effects of topically-applied tea extracts are complex and
cannot simply be reduced to anti-inflammatory properties
of polyphenols.
One of the leading symptoms of radiation-induced der-
matitis is inflammation, a major cause of discomfort for
patients undergoing radiotherapy. This makes the
involved molecular pro-inflammatory pathways a reason-
able target for supportive care. Inhibition of the proteas-
Representative EMSAFigure 4
Representative EMSA. Representative EMSA using total 
cellular extracts of RAW 264.7 cells after treatment with 
green tea extracts.
NF-kB
n.s.
free
oligonucleotide
Representative EMSAFigure 3
Representative EMSA. Representative EMSA using total 
cellular extracts of RAW 264.7 cells after treatment with 
black tea extracts.
NF-kB
n.s.
free
oligonucleotidePage 8 of 12
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polyphenols has been reported earlier [8]. In accordance
with previous reports, we showed that clinically-used
extracts from green and black tea exerted inhibitory effects
on all three cleavage activities of the proteasome in-vitro
and caused a significant decrease in the release of the pro-
inflammatory cytokines IL-1β, IL-6, IL-8, TNFα and PGE2
in our experimental system.
In addition to their proteasome inhibiting properties, tea
polyphenols and theaflavins have been shown to modu-
late NF-κB activity through the p38 MAPK pathway and
direct inhibition of IκB kinases [18,19]. Our results sup-
port the existence of an additional method by which tea
extracts may modulate the activity of these transcription
factors [20]. At high concentrations, tea extracts caused a
size shift of NF-κB subunit/DNA complexes. The observa-
tion that this size shift occurred less pronounced in MCF-
7 cells and that pre-treatment with the pan-caspase inhib-
itor z-VAD-fmk prevented this effect, indicated involve-
ment of caspases. The increased NF-κB activity at high
concentrations of tea extracts may also indicate a possible
cleavage of that part of the murine NF-κB subunit p65,
which interacts with the inhibitor IκB. Involvement of the
N-terminal part of human p65 in IκB binding has been
reported [24] but similar studies for murine NF-κB have
not been performed yet.
Previously, EGCG has been shown to protect from ioniz-
ing radiation, chemotherapy and UV radiation [25-27]. In
our study, tea at concentrations causing size shifts of NF-
κB complexes reduced the viability of murine macro-
phages. However, EGCG as well as tea extracts protected
the surviving cells from ionizing radiation. EGCG at con-
centrations similar to those of total tea polyphenols
expected in tea extracts [12] did not alter the activity of
Representative EMSAFigure 6
Representative EMSA. Representative EMSA using total 
cellular extracts of RAW 264.7 cells after treatment with 
black and green extracts and z-VAD-fmk.
NF-kB
n.s.
free
oligonucleotide
Representative EMSAFigure 5
Representative EMSA. Supershift assay using an anti-p50 
or anti-p65 antibody and lysates from RAW 264.7 cells.
NF-kB
n.s.
free
oligonucleotidePage 9 of 12
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BMC Medicine 2006, 4:28 http://www.biomedcentral.com/1741-7015/4/28NF-κB in the same way as whole tea extracts did. This
points to a complex mode of action for tea extracts and
could indicate that the anti-inflammatory effects of topi-
cally-applied tea extracts may at least partially depend on
tea constituents different from EGCG.
Taken together, our retrospective analysis of clinical data
showed that topically-applied green tea extracts were clin-
ically efficacious in the treatment of grade 2+ skin toxicity
during radiation therapy. However, the underlying mech-
anisms are most likely complex and involve antibacterial
and anti-inflammatory processes. Our in-vitro data indi-
cate that these mechanisms involve several different path-
ways, some of which might be dependent on tea
compounds other than polyphenols.
Conclusion
We conclude that tea extracts are efficient means to treat
radiation-induced skin toxicity. Understanding the under-
lying molecular mechanisms in the future may establish
tea extracts as a cheap and broadly available treatment for
skin toxicity caused by ionizing radiation in industrial as
well as developing countries during clinical radiotherapy
and in case of accidents involving ionizing radiation.
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MTT assay using RAW 264.7 cells after irradiationFigure 9
MTT assay using RAW 264.7 cells after irradiation. Cells were pretreated with tea extracts or EGCG at indicated con-
centrations.
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